
|Articles|November 6, 2012
LEO announces strategic collaborations for furthering advances in dermatology
LEO Pharma plans to establish five long-term research collaborations in four countries by the end of 2013 in an effort to deliver new treatment options to dermatology patients.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
What Dermatologists Need to Know About the First New Sunscreen Ingredient in Decades
5














